Literature DB >> 10414505

Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression.

L Quintanilla-Martinez1, J L Franklin, I Guerrero, L Krenacs, K N Naresh, C Rama-Rao, K Bhatia, M Raffeld, I T Magrath.   

Abstract

Nasal NK/T-cell lymphoma is a unique form of lymphoma highly associated with Epstein-Barr virus (EBV). These lymphomas are rare in Western populations and much more prevalent in some Asian and Latin American countries. Although there are several sizable studies from Asian countries, the same is not true from South America. The aim of this study was to analyze a series of 32 cases of nasal T-cell lymphoma from Peru and to further extend the characterization of this disease. Immunohistochemistry was performed on paraffin sections using the following antibodies: CD20 (L26), CD45RO, CD3, Ki67, CD57, CD56, TIA-1, bcl-2, and p53. The presence of EBV was investigated with immunohistochemical analysis for latent membrane protein (LMP)-1 and in situ hybridization using an antisense riboprobe to EBER 1. The 32 patients included 18 men and 14 women (M:F ratio, 1.2:1), with a median age of 43 years (11 to 72). Three categories were identified: (1) Nasal NK/T cell lymphomas (28 cases): The morphology ranged from small or medium-sized cells to large transformed cells. Necrosis was present in 86% of the cases, and angioinvasion was seen in 36% of the cases. All cases were positive for CD45RO, CD3, and for TIA-1. CD56 was positive in 21 of 27 cases (78%), and CD57 was negative in all cases. EBER 1 positivity was identified in most of the tumor cells in 27 of 28 cases (96%), including the six cases in which CD56 was negative. Overexpression of p53 was detected in 24 cases (86%). (2) Blastic NK cell lymphoma (1 case): The neoplastic cells resembled those of lymphoblastic lymphoma. CD56 and CD45RO were positive; TIA-1, TdT, and EBER-1 were negative. (3) Peripheral T-cell lymphoma (PTCL) unspecified (3 cases): CD56, TIA-1, and EBER-1 were negative. Nasal lymphomas from Peru with a T cell phenotype are predominantly EBV-associated NK/T cell lymphomas, similar to those described in Asian countries. The expression of CD56, TIA-1, and EBER-1, in combination, are very useful markers for the diagnosis of nasal NK/T cell lymphoma in paraffin-embedded tissue. The differential diagnosis of T-cell lymphomas in the nasal region should include rare cases of PTCL unspecified and the blastic variant of NK cell lymphoma. P53 is overexpressed in 86% of the cases. The significance of this finding with regard to clinical behavior and prognosis remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10414505     DOI: 10.1016/s0046-8177(99)90147-8

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  25 in total

1.  Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma.

Authors:  Hui-Hui Ma; Li-Ting Qian; Hai-Feng Pan; Lin Yang; Hong-Yan Zhang; Zhi-Hua Wang; Jun Ma; Yu-Fei Zhao; Jin Gao; Ai-Dong Wu
Journal:  Med Oncol       Date:  2009-08-15       Impact factor: 3.064

Review 2.  Virus-associated neoplasms of the nasopharynx and sinonasal tract: diagnostic problems.

Authors:  John Kc Chan
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

3.  p53 Mutations in nasal natural killer/T-cell lymphoma from Mexico: association with large cell morphology and advanced disease.

Authors:  L Quintanilla-Martinez; M Kremer; G Keller; M Nathrath; A Gamboa-Dominguez; A Meneses; L Luna-Contreras; A Cabras; H Hoefler; A Mohar; F Fend
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

4.  Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States.

Authors:  Scott V Adams; Polly A Newcomb; Andrei R Shustov
Journal:  J Clin Oncol       Date:  2016-03-20       Impact factor: 44.544

Review 5.  Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease.

Authors:  Keisei Kawa
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

6.  Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma.

Authors:  Adrien Chauchet; Anne-Sophie Michallet; Françoise Berger; Isabelle Bedgedjian; Eric Deconinck; Catherine Sebban; Daciana Antal; Hubert Orfeuvre; Bernadette Corront; Tony Petrella; Maya Hacini; Marie Bouteloup; Gilles Salles; Bertrand Coiffier
Journal:  J Hematol Oncol       Date:  2012-06-08       Impact factor: 17.388

Review 7.  Prognostic markers in peripheral T-cell lymphoma.

Authors:  Pier Paolo Piccaluga; Claudio Agostinelli; Anna Gazzola; Claudia Mannu; Francesco Bacci; Elena Sabattini; Stefano A Pileri
Journal:  Curr Hematol Malig Rep       Date:  2010-10       Impact factor: 3.952

8.  Bone marrow is involved in less than 10% of patients with nasal-type NK/T cell lymphoma at initial diagnosis.

Authors:  Chang Okh Sung; Young Hyeh Ko
Journal:  J Korean Med Sci       Date:  2004-04       Impact factor: 2.153

9.  Algorithmic Approach to Fibroinflammatory Sinonasal Tract Lesions.

Authors:  Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2021-03-15

10.  Comparison between presence of epstein barr virus in nodal and extra nodal diffuse large B cell lymphoma of head and neck, an Iranian experience.

Authors:  Mohammad Javad Ashraf; Alireza Makarempour; Ahmad Monabati; Negar Azarpira; Bijan Khademi; Afsoon Hakimzadeh; Elham Abedi; Bita Valibeigi
Journal:  Iran Red Crescent Med J       Date:  2012-12-06       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.